New pill aims to slow early Alzheimer's memory decline
NCT ID NCT07579884
First seen May 13, 2026 · Last updated May 21, 2026 · Updated 2 times
Summary
This study tests an experimental tablet called RP902 in people with mild cognitive impairment caused by Alzheimer's disease. The goal is to see if it can slow down memory and thinking problems. The trial will involve 360 participants across about 50 sites in China, and treatment lasts 48 weeks with an option to continue for up to 96 more weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD COGNITIVE IMPAIRMENT(MCI) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.